You are here: Industry Insights > price

News List

Pharma experts feel more drugs need price increase expresspharma
July 24, 2020
Recently, NPPA allowed 50 per cent price increase for heparin injection, which is also an essential medicine for the treatment of COVID-19 patients.
NPPA fixes retail prices for 40 formulations expresspharma
June 04, 2020
The authority has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013.
Will the industry sell COVID-19 meds at the min production costs? expresspharma
April 15, 2020
Will the pharma industry come through? Can the pharma industry resist pressures from investors and shareholders and sacrifice profits this time?
NPPA revises ceiling price of scheduled formulations expresspharma
April 07, 2020
In compliance of the provisions of Drugs (Price Control) Order 2013, the NPPA has revised/ increased the ceiling price of 883 scheduled formulations.
Sandoz to keep prices stable for potential coronavirus drugs pharmaceutical-technology
March 03, 2020
Novartis subsidiary Sandoz has said that the company would keep prices stable for a basket of medicines, which may have the potential to treat patients infected by coronavirus.
Three more companies raise their US drug list prices europeanpharmaceuticalreview
January 07, 2020
Novartis, Merck and Allergan have joined numerous other pharmaceutical companies by increasing the price of certain drugs since the start of 2020.
Over 250 drug list prices increased in 2020, says new report europeanpharmaceuticalreview
January 06, 2020
Drug makers have hiked the price of over 250 drugs in the US so far in 2020, according to new reports.
Drug makers file complaint for regulations to lower Canadian drug prices europeanpharmaceuticalreview
August 29, 2019
Five pharma companies have filed a complaint in Canadian court over new rules intended to lower the price of drugs in the country.
Prices Spike for Drugs Used to Treat Multiple Sclerosis drugs
August 28, 2019
From 2006 to 2016, the prices of self-administered disease-modifying therapies (DMTs) for multiple sclerosis increased, according to a study published online in JAMA Neurology.
Brand-name drug prices found to be rising at a slower pace in lower amounts europeanpharmaceuticalreview
August 23, 2019
Drug companies are still raising prices for brand-name prescription medicines but not as often or by as much as they used to.

Previous page 1 2 3 4 5 Next page